Assessment of functional results after percutaneous transluminal coronary angioplasty by cardiopulmonary exercise test

被引：12

作者：

Klainman, E

Fink, G

Lebzelter, J

Zafrir, N

机构：

[1] Mishmar Hayarden Cardiac & Rehabil Inst, Givatayim, Israel

[2] Rabin Med Ctr, Dept Pulm, Exercise Physiol Unit, Petah Tiqwa, Israel

[3] Rabin Med Ctr, Dept Cardiol, Exercise Physiol Unit, Petah Tiqwa, Israel

[4] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel

来源：

CARDIOLOGY | 1998年 / 89卷 / 04期

关键词：

cardiopulmonary exercise test; percutaneous transluminal coronary angioplasty; functional assessment; angiography; oxygen pulse;

D O I：

10.1159/000006797

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Twenty-nine patients with documented coronary artery disease underwent cardiopulmonary exercise tests before and following a percutaneous transluminal coronary angioplasty (PTCA). The patients medication regimen and exercise protocols remained the same in both cases. Following PTCA, significant improvement (p < 0.001-0.0001) was noted in oxygen consumption (1,526.8 +/- 470.0 vs. 1,686.2 +/- 390 ml/min), oxygen pulse (12.40 +/-: 2.73 vs. 13.44 +/- 2.9 ml/beat), oxygen pulse score(7.62 +/- 1.29 vs. 8.85 +/- 1.26 points) and in the ventilatory anaerobic threshold (993.1 +/- 177.6 vs. 1,089.8 +/- 150.9 ml/min) but not (p > 0.05) in maximal heart rate (128.7 +/- 16.9 vs. 132.0 +/- 17.2 beats/min). Thus, a cardiopulmonary exercise test is an effective method to assess functional results following PTCA.

引用

页码：257 / 262

页数：6

共 50 条

[21] THE EFFECT OF PRAVASTATIN ON PREVENTION OF RESTENOSIS AFTER SUCCESSFUL PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY
ONAKA, H
HIROTA, Y
KITA, Y
TSUJI, R
ISHII, K
ISHIMURA, T
KAWAMURA, K
JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1994, 58 (02): : 100 - 106
[22] BIOLOGICAL RISK-FACTORS FOR RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY
BENCHIMOL, D
BONNET, J
BENCHIMOL, H
DROUILLET, F
DUPLAA, C
COUFFINHAL, T
DESGRANGES, C
BRICAUD, H
INTERNATIONAL JOURNAL OF CARDIOLOGY, 1993, 38 (01) : 7 - 18
[23] ANGIOGRAPHIC-PATHOLOGICAL CORRELATIONS AFTER ELECTIVE PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY
NARUKO, T
UEDA, M
BECKER, AE
TOJO, O
TERAGAKI, M
TAKEUCHI, K
TAKEDA, T
CIRCULATION, 1993, 88 (04) : 1558 - 1568
[24] DIRECT AND INDIRECT COST OF PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY
FITZGERALD, ST
MERRILL, A
AVERSANO, T
SORKIN, A
CARDIOLOGY, 1994, 85 (05) : 298 - 302
[25] INTRACORONARY GALLOPAMIL DURING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY
RAUCH, B
RICHARDT, G
BARTH, R
ZIMMERMANN, R
TILLMANNS, H
SCHOMIG, A
KUBLER, W
NEUMANN, FJ
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 20 : S32 - S39
[26] THE PARADIGM OF RESTENOSIS FOLLOWING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY
PREISACK, MB
KARSCH, KR
EUROPEAN HEART JOURNAL, 1993, 14 : 187 - 192
[27] Association of an acute reduction in lipoprotein(a) with coronary artery restenosis after percutaneous transluminal coronary angioplasty
Horie, H
Takahashi, M
Izumi, M
Takaoka, A
Fujita, T
Sakamoto, T
Kito, O
Okamura, H
Kinoshita, M
CIRCULATION, 1997, 96 (01) : 166 - 173
[28] CORONARY-ARTERY FISTULA AS A COMPLICATION OF PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY
BATA, IR
MACDONALD, RG
ONEILL, BJ
CANADIAN JOURNAL OF CARDIOLOGY, 1993, 9 (04) : 331 - 335
[29] Prior cytomegalovirus infection and the risk of restenosis after percutaneous transluminal coronary balloon angioplasty
Manegold, C
Alwazzeh, M
Jablonowski, H
Adams, O
Medve, M
Seidlitz, B
Heidland, U
Häussinger, D
Strauer, BE
Heintzen, MP
CIRCULATION, 1999, 99 (10) : 1290 - 1294
[30] Major adverse outcomes after percutaneous transluminal coronary angioplasty: a clinical prediction rule
Fortescue, EB
Kahn, K
Bates, DW
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2003, 56 (01) : 17 - 27

← 1 2 3 4 5 →